BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3308292)

  • 21. Use of bolus intraperitoneal aminoglycosides for treating peritonitis in end-stage renal disease patients receiving continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis.
    Mars RL; Moles K; Pope K; Hargrove P
    Adv Perit Dial; 2000; 16():280-4. PubMed ID: 11045311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Infections in immunocompromised patients. II. Established therapy and its limitations.
    Periti P; Mazzei T
    Clin Ther; 1985; 8(1):100-17. PubMed ID: 3854579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changes in microbial ecology by therapeutic use of aminoglycosides.
    Bauernfeind A; Hörl G; Mönch V
    Scand J Infect Dis Suppl; 1986; 49():106-14. PubMed ID: 3547617
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical and clinical evaluation of once-daily aminoglycoside chemotherapy.
    Periti P
    J Chemother; 1995 Aug; 7(4):311-37. PubMed ID: 8568543
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Individualized monitoring of the therapy with gentamycin using pharmacokinetic methods. Which method to choose?].
    Carvalho A; Fonseca C; Falcão F; Pereira TA; Freitas O; Parrinha A; Costa M; Rodrigues MJ; Ceia F; Luís AS
    Acta Med Port; 1996; 9(7-9):187-95. PubMed ID: 9005695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative pharmacology: a focus on aminoglycosides.
    Bruce K; Hicks RW
    AORN J; 2011 Apr; 93(4):464-8; quiz 469-71. PubMed ID: 21459184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monitoring antibiotic therapy in the newborn infant.
    Craft JC
    Clin Perinatol; 1981 Jun; 8(2):263-72. PubMed ID: 7273587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosage adjustment of antiinfective therapy in patients with renal impairment.
    Eckhardt A; Borner K; Keller F; Zellner D
    Int J Clin Pharmacol Ther; 1997 Mar; 35(3):99-102. PubMed ID: 9088997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The aminoglycosides.
    Whelton A
    Clin Orthop Relat Res; 1984 Nov; (190):66-74. PubMed ID: 6386262
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of empiric aztreonam and aminoglycoside regimens in the treatment of serious gram-negative lower respiratory infections.
    Bjornson HS; Ramirez-Ronda C; Saavedra S; Rivera-Vázquez CR; Liu C; Hinthorn DR
    Clin Ther; 1993; 15(1):65-78. PubMed ID: 8458056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aminoglycoside nephrotoxicity.
    Swan SK
    Semin Nephrol; 1997 Jan; 17(1):27-33. PubMed ID: 9000547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic use in neonatal sepsis.
    Yurdakök M
    Turk J Pediatr; 1998; 40(1):17-33. PubMed ID: 9722468
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Aminoglycosides in the intensive care unit: an old drug in a dynamic environment.
    Miyagawa CI
    New Horiz; 1993 May; 1(2):172-80. PubMed ID: 7922400
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibilities of common gram negative bacilli to aminoglycosides and cephalosporins.
    Patamasucon P; Kalnauwakul S; Ratamaruesa A; Silpapojakul K
    J Med Assoc Thai; 1987 Sep; 70(9):511-5. PubMed ID: 3681179
    [No Abstract]   [Full Text] [Related]  

  • 35. First microbiological approach to dactimicin, a novel aminoglycoside antibiotic.
    Stefani S; Nicoletti G; Russo G; Toscano MA
    Drugs Exp Clin Res; 1987; 13(12):727-9. PubMed ID: 3447875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Monitoring of plasma concentrations of aminoglycosides].
    De Gregoris P; Follath F; Traditi F; De Rosa F
    Clin Ter; 1989 Aug 15-31; 130(3-4):153-8. PubMed ID: 2529089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aminoglycoside dosing considerations in intensive care unit patients.
    Watling SM; Dasta JF
    Ann Pharmacother; 1993 Mar; 27(3):351-7. PubMed ID: 8267695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parenteral aminoglycoside therapy. Selection, administration and monitoring.
    Kumana CR; Yuen KY
    Drugs; 1994 Jun; 47(6):902-13. PubMed ID: 7521830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aminoglycoside pharmacokinetic monitoring: an integral part of patient care?
    Rodvold KA; Zokufa H; Rotschafer JC
    Clin Pharm; 1988 Aug; 7(8):608-13. PubMed ID: 3048851
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacokinetics of antimicrobial drugs in cystic fibrosis. Aminoglycoside antibiotics.
    Horrevorts AM; Driessen OM; Michel MF; Kerrebijn KF
    Chest; 1988 Aug; 94(2 Suppl):120S-125S. PubMed ID: 3293937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.